Back to results
RecruitingPhase 2

An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

NCT07459660

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Clinical Site

Doral, Florida, United States

+2 additional locations

Contact

Clinical Trials Contact Center

+1 650 839 4380ML-007C-MA-ADP@maplightrx.com
View on ClinicalTrials.gov
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis — TrialFind